This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Trade & Channel Strategies
See you in 2023! Stay tuned for dates and announcements!
December 12-14, 2023Philadelphia, PA

Bill Roth
General Manager and Managing Partner at Blue Fin Group, An IntegriChain Company


Bill is the Founding Partner of Blue Fin Group, a management consulting firm and a division of IntegriChain. Bill is an expert in commercialization for every form of pharmaceuticals working for over 300 manufacturers including 29 of the top 30. He has rare experience working across the pharmaceutical ecosystem with all channels. Throughout his 30+ year career, he has consistently forecasted future events affecting the flow of pharmaceuticals.

Bill’s proudest accomplishments include being named youngest director for Cardinal Health in the mid-90s, starting his first venture-backed company at the age of 32, and being featured in Entrepreneur Magazine in 2001. In 2008 he was named PharmaVOICE magazine’s “Top 100 Most-Inspiring People in Life Sciences” and “People to Watch” by PM360 Magazine in 2009. In January of 2016, he was featured as the cover story of Pharmaceutical Commerce. Shortly thereafter, he began to present his 2030 vision for the pharmaceutical industry at multiple industry conferences.

He frequently keynotes at industry conferences such as ASHP, PCMA, NCODA, NCPA, HSCA, where he focuses on pharmaceutical commercialization. In addition, he has spoken at several Informa Connect and Asembia conferences.

On the topic of specialty and home infusion, Bill is a strong advocate of the market moving in this direction. Bill has worked with several national and regional providers helping design their business models and helps manufacturers understand the value and utility of the model.

Agenda Sessions

  • Current and Future Trends Impacting Trade and Distribution